Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Poliwogg Holdings

Request full access

Poliwogg publishes and licenses disease-specific indexes, which are designed to underlie financial instruments

New York City, United StatesFounded 2012Health

About Poliwogg Holdings

Poliwogg Holdings, Inc. operated as a financial services firm specializing in the creation of capital market tools for the healthcare and biopharmaceutical sectors. Founded in 2012, the company aimed to provide investors with novel ways to engage with the healthcare economy. The firm went out of business around October 2018, after having raised a seed round of $5.18 million in June 2015.

Poliwogg's business was structured around two distinct types of financial indexes. The first was Disease-Specific Indexes, which were designed to track the average cost per patient for treating a particular condition in the United States over a rolling twelve-month period. These indexes utilized comprehensive paid claims data to provide a basis for financial instruments like swaps, futures, and exchange-traded funds (ETFs), allowing entities within the healthcare ecosystem to hedge against financial risk. The inaugural index in this series tracked the treatment costs for Type 2 Diabetes.

The second part of their business was the creation of Poliwogg Equity Indexes, which focused on publicly traded companies in the U.S. healthcare sector, with a strong emphasis on the small to mid-capitalization biotechnology segment. These indexes employed metrics specific to the biotech and pharmaceutical industries. Key offerings included the Poliwogg Medical Breakthroughs Index (PMBI), the Poliwogg Healthcare Innovation Index (PHIX), and the Poliwogg Biopharma Merger & Acquisition Index (PBMA). The PMBI, which comprised small- and mid-cap biotech companies with at least one drug in Phase II or Phase III FDA clinical trials, was licensed to ALPS and served as the basis for the ALPS Medical Breakthroughs ETF (ticker: SBIO). In July 2019, the underlying index for the SBIO ETF was renamed to the S-Network® Medical Breakthroughs Index, though the methodology remained the same.

Source: Dealroom company data

Poliwogg Holdings in the New York City ecosystem

Live from Dealroom

The Poliwogg Holdings office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Poliwogg Holdings on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Poliwogg Holdings on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.